We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01176461
Recruitment Status : Active, not recruiting
First Posted : August 6, 2010
Last Update Posted : February 27, 2018
National Cancer Institute (NCI)
Bristol-Myers Squibb
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : December 12, 2016
  Estimated Study Completion Date : December 2018